Close menu




BAYER AG NA O.N.

Photo credits: pixabay.com

Commented by Juliane Zielonka on April 21st, 2022 | 13:58 CEST

Bayer AG, Perimeter Medical, Twitter - Shareholder interests drive share price performance

  • medtech
  • Technology

The life science and medical technology sectors offer investment opportunities. Whether with old hands like Bayer AG or up-and-coming innovative startups like Perimeter Medical, each company has its own fascination. Strong corporate management that acts in the interests of shareholders provides additional confidence. The latter, in particular, is currently being put to the test at the short messaging service Twitter. Elon Musk's takeover bid threatens to dilute existing investors' shares with a poison pill.

Read

Commented by Nico Popp on April 20th, 2022 | 12:04 CEST

Where the music is playing now: BioNTech, MAS Gold, Bayer

  • Gold
  • Biotech

Capitalism is the best system when it comes to distributing goods effectively. Supply and demand first make scarce goods expensive and then turn them into a promising business area. That is what happened with vaccines. Today, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is warning of an oversupply of Corona vaccines - two years ago, things looked very different. While biotech stocks such as BioNTech are being penalized, it is important to identify tomorrow's opportunities. Scarcity plays an important role here.

Read

Commented by Stefan Feulner on April 19th, 2022 | 12:10 CEST

Bayer, Defence Therapeutics, Formycon - Biotech stocks facing transformation

  • Biotechnology

The pharmaceutical industry proved to be a key industry in the Corona pandemic, developing tests, vaccines and drugs at record speed and making them available in large quantities. In the process, biotechnology emerged as the innovative engine. The development of new compounds is particularly important for the pharmaceutical industry, as patent protection for many blockbuster drugs will expire in the future or has already expired. For this reason, the pharmaceutical industry is now entering biotechs much more frequently in the early development phases of a new drug. As a result, early-stage development companies already offer opportunities for multiplication.

Read

Commented by Juliane Zielonka on April 15th, 2022 | 12:01 CEST

mm2 Asia, Nvidia, Bayer AG - Digital marketplaces with high scalability

  • entertainment
  • Digitization
  • nft

Shanghai is currently experiencing the totalitarian proportions of a zero-COVID strategy. Due to soaring cases, 26 million people have to go into a harsh lockdown. After more than two years of the pandemic, the images from the Chinese metropolis seem all the more disturbing. Helplessness is spreading. People are tired of the inhumane measures. Those who test positive have to spend their quarantine in specially equipped hospitals, separated from their families and other foreign positives. The dystopian experiences of the Corona Pandemic, which everyone has personally experienced in recent months, provide an unexpectedly timely stage for arguably the most spectacular re-mastering and launch on April 21 of an Asian indie film classic in the psychological thriller genre.

Read

Commented by André Will-Laudien on April 12th, 2022 | 18:27 CEST

Ukraine: K+S, Bayer, Ximen Mining - Fertilizer shares against the food disaster!

  • PreciousMetals
  • Agriculture

Ukraine is one of the leading export nations of wheat worldwide. However, the so-called "granary of Europe" does not primarily supply European countries because the main customers are mainly in Asia and North Africa. The most important destination for Ukrainian wheat in 2020, for example, was Egypt. The largest amount is transported overland to Odessa, where it is shipped. But now Putin has started bombing the important port city. Diesel and fertilizer are becoming scarce, so it is all the more important that there are Western specialists who are trying to secure a supply of food through special deliveries in fertilizer and technology. Where are the opportunities for investors?

Read

Commented by André Will-Laudien on April 4th, 2022 | 12:19 CEST

Bayer, Cardiol Therapeutics, Formycon, NanoRepro: Top Biotech Stocks - Delivering!

  • Biotechnology

Due to various public easing measures, the Corona pandemic is increasingly fading into the background. It has long been a hot ride for the stock market, especially for vaccine producers, but now investors are shifting their focus to other stocks in the biotech segment. After all, there are still many diseases that confront humanity with unresolved mysteries, and the field of human medical research seems endless. We focus on interesting stocks from the sector, which corrected strongly in the wake of the Ukraine downturn but are now trending north again. These trends are still in their infancy.

Read

Commented by Fabian Lorenz on March 24th, 2022 | 10:58 CET

Nel and Bayer shares in demand - when will Barsele Minerals explode?

  • Gold
  • Hydrogen

The stock and commodity markets remain volatile. Prices are driven by the war in Ukraine and the Corona pandemic. In recent days, commodities have been on the rise again. Brent oil is trading at around USD 120 per barrel, and gold is again setting its sights on the USD 2,000 mark. But even in this difficult-to-navigate environment, equities can make gains. Bayer shares, for example, have developed positively in recent weeks. And analysts see up to 50% upside potential for the DAX company. The invasion of Russia has also accelerated the move toward renewable energies. Hydrogen plays a central role in this. Nel has been able to profit from the fantasy in recent weeks and has now also announced a new order. Gold explorer Barsele Minerals has catch-up potential. According to a study, the share already had a lot of potential at a gold price of USD 1,350.

Read

Commented by Nico Popp on March 22nd, 2022 | 11:22 CET

In the right place at the right time: BioNTech, Defence Therapeutics, Bayer

  • Biotechnology

For years, the pandemic has kept the world on tenterhooks. Currently, the epidemic is taking a break, at least in the media. But while the world is looking tautly at Ukraine and more and more refugees are arriving in Germany, the Omicron figures are rising once more. In some cases, the incidence in Germany is over 3,000. Although fewer and fewer people are dying, more people than ever are in quarantine. We look at BioNTech, a typical pandemic stock, and present other exciting investments from the healthcare sector.

Read

Commented by Carsten Mainitz on March 16th, 2022 | 11:18 CET

Valneva, Perimeter Medical Imaging AI, Bayer - Immune to the crisis?

  • medtech

No sooner did the Corona pandemic seem to be under control than the world was shocked by the invasion of Russian troops in Ukraine. So far, the stock markets have digested the whole situation well. But even without further escalation, the supply situation for raw materials, among other things, will become more complex. The first signs are already awaiting us at the gas pumps. The rise in inflation will continue. Where should one invest given this mixed situation? Regardless of the economic and security situation, stocks from the healthcare sector are a good choice. Beyond fighting viruses or infectious diseases, there are great growth areas. Cancer is one such area. In addition, medical technology is increasingly bringing innovative technologies to the market, in some cases in conjunction with artificial intelligence, with disruption potential.

Read

Commented by Juliane Zielonka on March 15th, 2022 | 13:19 CET

BASF, Almonty Industries, Bayer - These stocks are providing the momentum

  • Tungsten

New battery technology from BASF promises faster charging times. The Ludwigshafen-based conglomerate talks of 15 minutes for charging an e-car with a 600km range. New batteries require the appropriate materials, such as the element tungsten. In this area, Almonty Industries provides supplies thanks to its resource-rich mine in South Korea. Meanwhile, Bayer AG in Leverkusen is busy shrinking itself back to health. Bayer's stock has been rising somewhat since it was announced that it was divesting its pest control division.

Read